Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 145Precursor Cell Lymphoblastic Leukemia-Lymphoma 110Lymphoma, Large B-Cell, Diffuse 89Leukemia 74Lymphoma, Non-Hodgkin 60Lymphoma, Follicular 47Burkitt Lymphoma 46Lymphoma, Mantle-Cell 43Hodgkin Disease 31Neuroblastoma 30Central Nervous System Neoplasms 29Sarcoma 24Lymphoma, Large-Cell, Immunoblastic 23Lymphoma, Large-Cell, Anaplastic 21Multiple Myeloma 19Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, B-Cell, Marginal Zone 15HIV Infections 15Brain Neoplasms 15Medulloblastoma 11Dendritic Cell Sarcoma, Interdigitating 11Astrocytoma 11Acquired Immunodeficiency Syndrome 11Wilms Tumor 10Rhabdomyosarcoma 10Lymphoma, T-Cell, Peripheral 10Lymphoma, B-Cell 10Recurrence 9Oligodendroglioma 9Neuroectodermal Tumors, Primitive, Peripheral 9

Interventions

mogamulizumab 4Lenalidomide 3Cyclophosphamide 3Alemtuzumab 2peginterferon alfa-2b 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1cobomarsen 1belinostat 1Zidovudine 1Vincristine 1Raltegravir Potassium 1Prednisone 1Oxaliplatin 1Introns 1Interleukin-15 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Etoposide 1Doxorubicin 1Dexamethasone 1Daclizumab 1Cytarabine 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1B3(Fv)-PE38KDEL recombinant immunotoxin 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia-Lymphoma, Adult T-Cell × Vincristine × Clear all
NCT01000285 2017-03-28

ATLL

Washington University School of Medicine

Phase 1/2 Completed
18 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡